<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D6784BA3-960E-40CB-8663-A597913E4CF5"><gtr:id>D6784BA3-960E-40CB-8663-A597913E4CF5</gtr:id><gtr:firstName>D</gtr:firstName><gtr:surname>Higgs</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15069"><gtr:id>08C40499-F9E5-4650-9625-1C5D65A3366C</gtr:id><gtr:title>Developing an initiative in stem cell editing for human genetic diseases.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15069</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The recent development of genome editing using programmable nucleases has already transformed our ability to perform experiments in mammalian cells rapidly, at high throughput and with high precision. The next challenge is to apply this discovery to precisely edit and correct genetic defects in human stem cells in a new approach to the treatment of inherited diseases. In this proposal we aim to address the key preclinical hurdles in achieving this by editing haematopoietic stem cells from patients with severe haemoglobinopathies, with the goal of rapidly progressing this knowledge to early phase clinical trials.
Using flexible funding allocated to the University as a block grant, we will facilitate the development of this new initiative bringing together the considerable expertise and technical know-how in a wide range of interdisciplinary groups to address this focussed problem. We anticipate that genome editing will ultimately find application in a wide range of human diseases and the University of Oxford is fully committed to support its early development in blood diseases to establish the principles of this approach and the longer term application of this exciting new technology to a broad range of challenges in clinical medicine.</gtr:technicalSummary><gtr:fund><gtr:end>2017-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1000000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>399179</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>John Fell Fund</gtr:department><gtr:description>The Oxford Single Cell Biology Consortium</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>563796EC-728E-4563-8D41-CFF3102EF22C</gtr:id><gtr:outcomeId>58b82a7a333456.87336602</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>173793</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>John Fell Fund</gtr:department><gtr:description>Developing a programme for stem cell editing for human blood diseases</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>14A280BE-D7D4-4141-9E19-07E5381ACCC3</gtr:id><gtr:outcomeId>58b82aeab80948.02499603</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The IP covers the Next Generation Capture-C method for massively multiplexed 3C analysis of genome interactions</gtr:description><gtr:grantRef>MC_PC_15069</gtr:grantRef><gtr:id>F5333F09-7A39-4BFD-8B14-2268E5F1AAD2</gtr:id><gtr:impact>None so far</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58b82e1c2e1e38.60695333</gtr:outcomeId><gtr:patentId>PCT/GB2016/053314</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>NG Capture C</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>34ECD5A2-913F-4960-9865-82D8073FC2B0</gtr:id><gtr:title>Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/688e1c764745aec0d9fd4c761052bef0"><gtr:id>688e1c764745aec0d9fd4c761052bef0</gtr:id><gtr:otherNames>Snelling SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a6f2d1161b7b0.92686762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B021CD52-4127-4A0B-A67F-8C617A1FFF58</gtr:id><gtr:title>Chronic inflammation is a feature of Achilles tendinopathy and rupture.</gtr:title><gtr:parentPublicationTitle>British journal of sports medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8a783e67f3fe9432f840ccd1d01778c"><gtr:id>b8a783e67f3fe9432f840ccd1d01778c</gtr:id><gtr:otherNames>Dakin SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0306-3674</gtr:issn><gtr:outcomeId>5a6f2cf029f0c9.95778862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A19653AC-C09D-4266-A148-160EDB41418F</gtr:id><gtr:title>Selective silencing of a-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>58b6af64c81418.65892648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E823ECF-E8DE-46A2-B47A-20DD28EC9DEB</gtr:id><gtr:title>Robust detection of chromosomal interactions from small numbers of cells using low-input Capture-C.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76bdd222d2fda6fbb041ce1329f33732"><gtr:id>76bdd222d2fda6fbb041ce1329f33732</gtr:id><gtr:otherNames>Oudelaar AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5a6f2de1316118.57486220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43E3CDD9-4AC5-46B3-B9E3-7BA332054CF3</gtr:id><gtr:title>Genetic dissection of the a-globin super-enhancer in vivo.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4372a7f2d5ea1d6313b49e5c539a538"><gtr:id>f4372a7f2d5ea1d6313b49e5c539a538</gtr:id><gtr:otherNames>Hay D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b6af648844e9.80201951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AE11F1E-D262-4A3B-A50D-68BB386A57BB</gtr:id><gtr:title>The role of national registries in improving patient safety for hip and knee replacements.</gtr:title><gtr:parentPublicationTitle>BMC musculoskeletal disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2169cf6cc0f970e1fc00efde96058a97"><gtr:id>2169cf6cc0f970e1fc00efde96058a97</gtr:id><gtr:otherNames>L?bbeke A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2474</gtr:issn><gtr:outcomeId>5a6f2de2b2cdc4.40061445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DA084F2-F4A0-4CA8-97AA-EEB62821EDE3</gtr:id><gtr:title>Increased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8a783e67f3fe9432f840ccd1d01778c"><gtr:id>b8a783e67f3fe9432f840ccd1d01778c</gtr:id><gtr:otherNames>Dakin SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a6f2d6e23c789.37866702</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15069</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>